← Eichor
Study identifier: NCT05237986 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

Condition: Lymphoma · Leukemia  ·  Sponsor: National Cancer Institute (NCI)

PhaseN/A
Planned participants60
Who can joinAll sexes, 5 Years to no upper limit
Healthy volunteersYes

About this study

Background: CAR T-cell therapy is a promising new treatment for blood cancers. During treatment, a person s T-cells are genetically changed to kill cancer cells. Researchers want to learn more about the effects of potential problems that may be associated with this treatment. We are specifically interested in learning if and how this treatment may affect the brain or your thinking skills. Objective: To learn if CAR T-cell therapy can affect how children and adults think, process, and remember things. Eligibility: People aged 5-35 who have blood cancer that has not responded to treatment, or the blood cancer has come back after treatment, and who will receive CAR T-cell therapy. Caregivers are also needed. All participants must be able to speak and read in English or Spanish. Design: Participants will be screened with a medical history. Information from participants medical records will be collected. Participants will take tests at home or at NIH to see how well they think, read, learn, remember, reason, and pay attention. The tests will be both computerized and paper/pencil. They will take less than 1 hour to complete. Participants and a parent/adult observer will complete a 5-minute Background Information Form and a checklist of nervous system symptoms. If participants are 5 years or older, they will participate in activities to test their ability to do different thinking tasks, like answer questions, complete puzzle patterns, and remember things. Participants an…

This description comes directly from the study's public registry record.

Talk to the study team

NCI Ped LeukemiaLymph Cell Tx Tm  ·  (240) 760-6970  ·  ncilltct@mail.nih.gov

Pamela L Wolters, Ph.D.  ·  (240) 760-6035  ·  woltersp@mail.nih.gov

Always discuss trial participation with your own doctor first.

Locations (3)

Children s Hospital of Los AngelesLos Angeles, California, United StatesRecruiting
National Institutes of Health Clinical CenterBethesda, Maryland, United StatesRecruiting
Seattle Children s HospitalSeattle, Washington, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05237986